| id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S4893 R12916 |
Broms (Controls exposed to other treatments), 2020 | Caesarean section | 3 months (or more) before pregnancy or during pregnancy | population based cohort retrospective | exposed to other treatment, sick excluded | Adjustment: No |
1.79 [1.39;2.30] C excluded (control group) |
103/257 2,560/9,393 | 2,663 | 257 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S4892 R12911 |
Broms (Controls unexposed, disease free), 2020 | Caesarean section | 3 months (or more) before pregnancy or during pregnancy excluded | population based cohort retrospective | unexposed, disease free | Adjustment: No |
3.19 [2.48;4.09] C excluded (exposition period) |
103/257 281,654/1,623,483 | 281,757 | 257 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5066 R13190 |
De Lorenzo (Controls unexposed, disease free), 2020 | Caesarean | at least 1st trimester | retrospective cohort | unexposed, disease free excluded | Adjustment: No |
0.93 [0.03;24.84] C excluded (control group) |
0/2 9/36 | 9 | 2 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5067 R13196 |
De Lorenzo (Controls unexposed, sick), 2020 | Caesarean | at least 1st trimester excluded | retrospective cohort | unexposed, sick | Adjustment: No |
0.46 [0.02;12.10] C excluded (exposition period) |
0/2 13/32 | 13 | 2 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5069 R13215 |
Chambers (Controls unexposed, disease free), 2019 | Delivery by Caesarian Section | at least 1st trimester | prospective cohort | unexposed, disease free excluded | Adjustment: No |
2.34 [1.56;3.51] C excluded (control group) |
107/220 57/198 | 164 | 220 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5068 R13200 |
Chambers (Controls, sick), 2019 | Delivery by Caesarian Section | at least 1st trimester excluded | prospective cohort | unexposed, sick | Adjustment: No |
1.33 [0.84;2.13] C excluded (exposition period) |
107/220 44/106 | 151 | 220 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 0 studies | NaN [NaN;NaN] | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||